» Articles » PMID: 23757427

Reduced Hypoglycemia and Increased Time in Target Using Closed-loop Insulin Delivery During Nights with or Without Antecedent Afternoon Exercise in Type 1 Diabetes

Overview
Journal Diabetes Care
Specialty Endocrinology
Date 2013 Jun 13
PMID 23757427
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Afternoon exercise increases the risk of nocturnal hypoglycemia (NH) in subjects with type 1 diabetes. We hypothesized that automated feedback-controlled closed-loop (CL) insulin delivery would be superior to open-loop (OL) control in preventing NH and maintaining a higher proportion of blood glucose levels within the target blood glucose range on nights with and without antecedent afternoon exercise.

Research Design And Methods: Subjects completed two 48-h inpatient study periods in random order: usual OL control and CL control using a proportional-integrative-derivative plus insulin feedback algorithm. Each admission included a sedentary day and an exercise day, with a standardized protocol of 60 min of brisk treadmill walking to 65-70% maximum heart rate at 3:00 p.m.

Results: Among 12 subjects (age 12-26 years, A1C 7.4±0.6%), antecedent exercise increased the frequency of NH (reference blood glucose<60 mg/dL) during OL control from six to eight events. In contrast, there was only one NH event each on nights with and without antecedent exercise during CL control (P=0.04 vs. OL nights). Overnight, the percentage of glucose values in target range was increased with CL control (P<0.0001). Insulin delivery was lower between 10:00 p.m. and 2:00 a.m. on nights after exercise on CL versus OL, P=0.008.

Conclusions: CL insulin delivery provides an effective means to reduce the risk of NH while increasing the percentage of time spent in target range, regardless of activity level in the mid-afternoon. These data suggest that CL control could be of benefit to patients with type 1 diabetes even if it is limited to the overnight period.

Citing Articles

7. Diabetes Technology: Standards of Care in Diabetes-2025.

Diabetes Care. 2024; 48(Supplement_1):S146-S166.

PMID: 39651978 PMC: 11635043. DOI: 10.2337/dc25-S007.


Nutritional Management of Athletes with Type 1 Diabetes: A Narrative Review.

Cavallo M, De Fano M, Barana L, Dozzani I, Bianchini E, Pellegrino M Nutrients. 2024; 16(6).

PMID: 38542818 PMC: 10975101. DOI: 10.3390/nu16060907.


Associations between daily step count classifications and continuous glucose monitoring metrics in adults with type 1 diabetes: analysis of the Type 1 Diabetes Exercise Initiative (T1DEXI) cohort.

Turner L, Marak M, Gal R, Calhoun P, Li Z, Jacobs P Diabetologia. 2024; 67(6):1009-1022.

PMID: 38502241 DOI: 10.1007/s00125-024-06127-2.


Recent advances in the precision control strategy of artificial pancreas.

Ming W, Guo X, Zhang G, Liu Y, Wang Y, Zhang H Med Biol Eng Comput. 2024; 62(6):1615-1638.

PMID: 38418768 DOI: 10.1007/s11517-024-03042-x.


7. Diabetes Technology: Standards of Care in Diabetes-2024.

Diabetes Care. 2023; 47(Suppl 1):S126-S144.

PMID: 38078575 PMC: 10725813. DOI: 10.2337/dc24-S007.


References
1.
Banarer S, Cryer P . Sleep-related hypoglycemia-associated autonomic failure in type 1 diabetes: reduced awakening from sleep during hypoglycemia. Diabetes. 2003; 52(5):1195-203. DOI: 10.2337/diabetes.52.5.1195. View

2.
Tsalikian E, Kollman C, Tamborlane W, Beck R, Fiallo-Scharer R, Fox L . Prevention of hypoglycemia during exercise in children with type 1 diabetes by suspending basal insulin. Diabetes Care. 2006; 29(10):2200-4. PMC: 1584283. DOI: 10.2337/dc06-0495. View

3.
El-Khatib F, Russell S, Nathan D, Sutherlin R, Damiano E . A bihormonal closed-loop artificial pancreas for type 1 diabetes. Sci Transl Med. 2010; 2(27):27ra27. PMC: 4242106. DOI: 10.1126/scitranslmed.3000619. View

4.
Steil G, Rebrin K, Darwin C, Hariri F, Saad M . Feasibility of automating insulin delivery for the treatment of type 1 diabetes. Diabetes. 2006; 55(12):3344-50. DOI: 10.2337/db06-0419. View

5.
Kovatchev B, Cobelli C, Renard E, Anderson S, Breton M, Patek S . Multinational study of subcutaneous model-predictive closed-loop control in type 1 diabetes mellitus: summary of the results. J Diabetes Sci Technol. 2010; 4(6):1374-81. PMC: 3005047. DOI: 10.1177/193229681000400611. View